Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

A new human (psycho)pharmacology tool: the multiple organs coincidences counter (MOCC).

Malizia A, Forse G, Haida A, Gunn R, Melichar J, Poole K, Bateman D, Fahy D, Schnorr L, Brown D, Rhodes C, Nutt DJ, Jones T.

J Psychopharmacol. 1995 Jan;9(4):294-306. doi: 10.1177/026988119500900402.

PMID:
22298393
2.

Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo.

Malizia AL, Gunn RN, Wilson SJ, Waters SH, Bloomfield PM, Cunningham VJ, Nutt DJ.

Neuropharmacology. 1996;35(9-10):1483-91.

PMID:
9014164
3.

Preclinical pharmacology and pharmacokinetics of AZD3783, a selective 5-hydroxytryptamine 1B receptor antagonist.

Zhang M, Zhou D, Wang Y, Maier DL, Widzowski DV, Sobotka-Briner CD, Brockel BJ, Potts WM, Shenvi AB, Bernstein PR, Pierson ME.

J Pharmacol Exp Ther. 2011 Nov;339(2):567-78. doi: 10.1124/jpet.110.174433. Epub 2011 Aug 8.

4.

Demonstration of clomipramine and venlafaxine occupation at serotonin reuptake sites in man in vivo.

Malizia AL, Melichar JM, Brown DJ, Gunn RN, Reynolds A, Jones T, Nutt DJ.

J Psychopharmacol. 1997;11(3):279-81.

PMID:
9305421
5.

In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates.

Brouillet E, Chavoix C, Bottlaender M, Khalili-Varasteh M, Hantraye P, Fournier D, Dodd RH, Mazière M.

Brain Res. 1991 Aug 23;557(1-2):167-76.

PMID:
1660750
6.

D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.

Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D, Werkheiser J, Widzowski D, Mrzljak L, Maier D.

Synapse. 2010 Aug;64(8):624-33. doi: 10.1002/syn.20771.

PMID:
20340171
7.

Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers.

Melichar JK, Haida A, Rhodes C, Reynolds AH, Nutt DJ, Malizia AL.

J Psychopharmacol. 2001 Mar;15(1):9-12.

PMID:
11277612
9.

Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo.

Malizia AL, Melichar JK, Rhodes CG, Haida A, Reynolds AH, Jones T, Nutt DJ.

Eur J Pharmacol. 2000 Mar 17;391(3):263-7.

PMID:
10729367
10.

Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.

Andrée B, Halldin C, Thorberg SO, Sandell J, Farde L.

Nucl Med Biol. 2000 Jul;27(5):515-21.

PMID:
10962260
11.

Molecular imaging of cardiac sympathetic innervation by 11C-mHED and PET: from man to mouse?

Law MP, Schäfers K, Kopka K, Wagner S, Schober O, Schäfers M.

J Nucl Med. 2010 Aug;51(8):1269-76. doi: 10.2967/jnumed.110.074997.

12.

Dynamic monitoring of [11C]diprenorphine in rat brain using a prototype positron imaging device.

Rajeswaran S, Hume SP, Cremer JE, Young J, Bailey DL, Ashburner J, Luthra SK, Jones AK, Jones T.

J Neurosci Methods. 1991 Dec;40(2-3):223-32.

PMID:
1800857
13.

Sensitivity of binding of high-affinity dopamine receptor radioligands to increased synaptic dopamine.

Gatley SJ, Gifford AN, Carroll FI, Volkow ND.

Synapse. 2000 Dec 15;38(4):483-8.

PMID:
11044896
14.

Occupancy of human brain GABA(A) receptors by the novel α5 subtype-selective benzodiazepine site inverse agonist α5IA as measured using [¹¹C]flumazenil PET imaging.

Eng W, Atack JR, Bergstrom M, Sanabria S, Appel L, Dawson GR, Sciberras D, Hargreaves RJ, Langstrom B, Burns HD.

Neuropharmacology. 2010 Dec;59(7-8):635-9. doi: 10.1016/j.neuropharm.2010.07.024. Epub 2010 Aug 7.

PMID:
20696179
15.

Displacement of RTI-55 from the dopamine transporter by cocaine.

Gatley SJ, Volkow ND, Chen R, Fowler JS, Carroll FI, Kuhar MJ.

Eur J Pharmacol. 1996 Jan 25;296(2):145-51.

PMID:
8838450
16.

[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.

Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):17-24.

PMID:
9459568
17.

Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.

Andrée B, Nyberg S, Ito H, Ginovart N, Brunner F, Jaquet F, Halldin C, Farde L.

J Clin Psychopharmacol. 1998 Aug;18(4):317-23.

PMID:
9690698
18.

Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.

Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, Howell LL.

Synapse. 2002 Jan;43(1):78-85.

PMID:
11746736
19.

In vivo characterization and dynamic receptor occupancy imaging of TPA023B, an alpha 2/alpha 3/alpha 5 subtype selective gamma-aminobutyric acid-a partial agonist.

Van Laere K, Bormans G, Sanabria-Bohórquez SM, de Groot T, Dupont P, De Lepeleire I, de Hoon J, Mortelmans L, Hargreaves RJ, Atack JR, Burns HD.

Biol Psychiatry. 2008 Jul 15;64(2):153-61. doi: 10.1016/j.biopsych.2008.01.021. Epub 2008 Mar 14.

PMID:
18339360
20.

Understanding the central pharmacokinetics of spheroidal oral drug absorption system (SODAS) dexmethylphenidate: a positron emission tomography study of dopamine transporter receptor occupancy measured with C-11 altropane.

Spencer TJ, Bonab AA, Dougherty DD, Mirto T, Martin J, Clarke A, Fischman AJ.

J Clin Psychiatry. 2012 Mar;73(3):346-52. doi: 10.4088/JCP.10m06393. Epub 2011 Nov 1.

PMID:
22154896
Items per page

Supplemental Content

Write to the Help Desk